These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 20615910

  • 1. Urinary angiotensinogen reflects the activity of intrarenal renin-angiotensin system in patients with IgA nephropathy.
    Nishiyama A, Konishi Y, Ohashi N, Morikawa T, Urushihara M, Maeda I, Hamada M, Kishida M, Hitomi H, Shirahashi N, Kobori H, Imanishi M.
    Nephrol Dial Transplant; 2011 Jan; 26(1):170-7. PubMed ID: 20615910
    [Abstract] [Full Text] [Related]

  • 2. Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients.
    Kobori H, Alper AB, Shenava R, Katsurada A, Saito T, Ohashi N, Urushihara M, Miyata K, Satou R, Hamm LL, Navar LG.
    Hypertension; 2009 Feb; 53(2):344-50. PubMed ID: 19075095
    [Abstract] [Full Text] [Related]

  • 3. Changes in urinary angiotensinogen posttreatment in pediatric IgA nephropathy patients.
    Urushihara M, Nagai T, Kinoshita Y, Nishiyama S, Suga K, Ozaki N, Jamba A, Kondo S, Kobori H, Kagami S.
    Pediatr Nephrol; 2015 Jun; 30(6):975-82. PubMed ID: 25523477
    [Abstract] [Full Text] [Related]

  • 4. Poor glycemic control and decreased renal function are associated with increased intrarenal RAS activity in Type 2 diabetes mellitus.
    Nakatani S, Ishimura E, Naganuma T, Nakatani A, Ichii M, Fukumoto S, Mori K, Emoto M, Nakatani T, Inaba M.
    Diabetes Res Clin Pract; 2014 Jul; 105(1):40-6. PubMed ID: 24846444
    [Abstract] [Full Text] [Related]

  • 5. Urinary angiotensinogen as a predictive marker in patients with immunoglobulin A nephropathy.
    Kim YG, Song SB, Lee SH, Moon JY, Jeong KH, Lee TW, Ihm CG.
    Clin Exp Nephrol; 2011 Oct; 15(5):720-726. PubMed ID: 21695414
    [Abstract] [Full Text] [Related]

  • 6. Relationship between urinary angiotensinogen and salt sensitivity of blood pressure in patients with IgA nephropathy.
    Konishi Y, Nishiyama A, Morikawa T, Kitabayashi C, Shibata M, Hamada M, Kishida M, Hitomi H, Kiyomoto H, Miyashita T, Mori N, Urushihara M, Kobori H, Imanishi M.
    Hypertension; 2011 Aug; 58(2):205-11. PubMed ID: 21670416
    [Abstract] [Full Text] [Related]

  • 7. Urinary angiotensinogen accurately reflects intrarenal Renin-Angiotensin system activity.
    Urushihara M, Kondo S, Kagami S, Kobori H.
    Am J Nephrol; 2010 Aug; 31(4):318-25. PubMed ID: 20160435
    [Abstract] [Full Text] [Related]

  • 8. Night-time activation of the intrarenal renin-angiotensin system due to nocturnal hypertension is associated with renal arteriosclerosis in normotensive IgA nephropathy patients.
    Ohashi N, Isobe S, Matsuyama T, Ishigaki S, Tsuji N, Fujikura T, Tsuji T, Kato A, Yasuda H.
    Hypertens Res; 2018 May; 41(5):334-341. PubMed ID: 29507351
    [Abstract] [Full Text] [Related]

  • 9. ELISA examining urinary angiotensinogen as a potential indicator of intrarenal renin-angiotensin system (RAS) activity: a clinical study of 128 chronic kidney disease patients.
    Zhang XY, Ding XQ, Lv WL, Teng J, Zhong YH.
    Mol Biol Rep; 2013 Oct; 40(10):5817-24. PubMed ID: 24065527
    [Abstract] [Full Text] [Related]

  • 10. Urinary renin, but not angiotensinogen or aldosterone, reflects the renal renin-angiotensin-aldosterone system activity and the efficacy of renin-angiotensin-aldosterone system blockade in the kidney.
    van den Heuvel M, Batenburg WW, Jainandunsing S, Garrelds IM, van Gool JM, Feelders RA, van den Meiracker AH, Danser AH.
    J Hypertens; 2011 Nov; 29(11):2147-55. PubMed ID: 21941204
    [Abstract] [Full Text] [Related]

  • 11. Intrarenal RAS activity and urinary angiotensinogen excretion in anti-thymocyte serum nephritis rats.
    Ohashi N, Yamamoto T, Huang Y, Misaki T, Fukasawa H, Suzuki H, Togawa A, Suzuki S, Fujigaki Y, Nakagawa T, Nakamura Y, Suzuki F, Kitagawa M, Hishida A.
    Am J Physiol Renal Physiol; 2008 Nov; 295(5):F1512-8. PubMed ID: 18784264
    [Abstract] [Full Text] [Related]

  • 12. The effects of dual blockade of the renin-angiotensin system on urinary protein and transforming growth factor-beta excretion in 2 groups of patients with IgA and diabetic nephropathy.
    Song JH, Lee SW, Suh JH, Kim ES, Hong SB, Kim KA, Kim MJ.
    Clin Nephrol; 2003 Nov; 60(5):318-26. PubMed ID: 14640237
    [Abstract] [Full Text] [Related]

  • 13. The Intrarenal Renin-angiotensin System Is Activated Immediately after Kidney Donation in Kidney Transplant Donors.
    Ohashi N, Isobe S, Matsuyama T, Ishigaki S, Suzuki T, Tsuji T, Otsuka A, Kato A, Miyake H, Yasuda H.
    Intern Med; 2019 Mar 01; 58(5):643-648. PubMed ID: 30333423
    [Abstract] [Full Text] [Related]

  • 14. The Urinary Angiotensinogen to Urinary Albumin Ratio Reflects Whether the Renin-angiotensin System in the Kidney Is Activated due to Filtration of Plasma Angiotensinogen through the Damaged Glomeruli or the Production of Angiotensinogen in the Proximal Tubules.
    Ohashi N, Aoki T, Matsuyama T, Ishigaki S, Isobe S, Katahashi N, Sato T, Fujikura T, Kato A, Yasuda H.
    Intern Med; 2020 Feb 01; 59(3):357-364. PubMed ID: 31534091
    [Abstract] [Full Text] [Related]

  • 15. Increased urinary excretion of angiotensinogen is associated with risk of chronic kidney disease.
    Mills KT, Kobori H, Hamm LL, Alper AB, Khan IE, Rahman M, Navar LG, Liu Y, Browne GM, Batuman V, He J, Chen J.
    Nephrol Dial Transplant; 2012 Aug 01; 27(8):3176-81. PubMed ID: 22399491
    [Abstract] [Full Text] [Related]

  • 16. Chronotherapy with a Renin-angiotensin System Inhibitor Ameliorates Renal Damage by Suppressing Intrarenal Renin-angiotensin System Activation.
    Aoki T, Ohashi N, Isobe S, Ishigaki S, Matsuyama T, Sato T, Fujikura T, Kato A, Miyajima H, Yasuda H.
    Intern Med; 2020 Aug 01; 59(18):2237-2244. PubMed ID: 32938851
    [Abstract] [Full Text] [Related]

  • 17. Urinary angiotensinogen excretion is associated with blood pressure independent of the circulating renin-angiotensin system in a group of african ancestry.
    Michel FS, Norton GR, Maseko MJ, Majane OH, Sareli P, Woodiwiss AJ.
    Hypertension; 2014 Jul 01; 64(1):149-56. PubMed ID: 24777983
    [Abstract] [Full Text] [Related]

  • 18. Altered urinary excretion of aquaporin 2 in IgA nephropathy.
    Rocchetti MT, Tamma G, Lasorsa D, Suriano IV, D'Apollo A, Papale M, Mastrofrancesco L, Grandaliano G, Svelto M, Valenti G, Gesualdo L, Di Paolo S.
    Eur J Endocrinol; 2011 Oct 01; 165(4):657-64. PubMed ID: 21824900
    [Abstract] [Full Text] [Related]

  • 19. The Relationship between the Intrarenal Dopamine System and Intrarenal Renin-angiotensin System Depending on the Renal Function.
    Matsuyama T, Ohashi N, Ishigaki S, Isobe S, Tsuji N, Fujikura T, Tsuji T, Kato A, Miyajima H, Yasuda H.
    Intern Med; 2018 Nov 15; 57(22):3241-3247. PubMed ID: 29984779
    [Abstract] [Full Text] [Related]

  • 20. Urinary angiotensinogen as a potential biomarker of intrarenal renin-angiotensin system activity in Chinese chronic kidney disease patients.
    Xu Z, Xu B, Xu C.
    Ir J Med Sci; 2015 Jun 15; 184(2):297-304. PubMed ID: 24664631
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.